Amphastar Pharmaceuticals (AMPH) Price to FCF (2014 - 2026)

Amphastar Pharmaceuticals has reported Price to FCF for 13 years, with the latest figure at 20.09 in Q2 2026.

• On a quarterly basis, Price to FCF fell 52.91% year-over-year to 20.09 in Q2 2026; TTM through Jun 2026 was 5.61, a 41.0% decrease from a year earlier, with the FY2025 full-year figure at 10.08, down 1.71% from the prior year.
• Price to FCF was 20.09 for Q2 2026 at Amphastar Pharmaceuticals, down from 22.81 in the prior quarter.
• The five-year high for Price to FCF was 206.15 in Q4 2023, with the low at 661.41 in Q2 2022.
• Average Price to FCF over 5 years is 24.51, with a median of 47.92 recorded in 2024.
• The largest YoY upside for Price to FCF was 356.66% in 2022 against a maximum downside of 1906.28% in 2022.
• Over 5 years, Price to FCF stood at 151.2 in 2022, then surged by 36.34% to 206.15 in 2023, then slumped by 48.37% to 106.43 in 2024, then tumbled by 53.29% to 49.71 in 2025, then plunged by 59.59% to 20.09 in 2026.
• The last three Price to FCF figures came in at 20.09 (Q2 2026), 22.81 (Q1 2026), and 49.71 (Q4 2025), per Business Quant data.